Her main research concerns Schizophrenia, Psychosis, Neuroscience, Ketamine and Anterior cingulate cortex. The concepts of her Schizophrenia study are interwoven with issues in Haloperidol, Glutamate receptor and Internal medicine, Hippocampus, Cerebral blood flow. Her studies deal with areas such as Motion, Memoria, Motor control, Resting state fMRI and Antipsychotic as well as Psychosis.
Her Neuroscience research is multidisciplinary, incorporating elements of NMDA receptor and Glutamatergic. Her Ketamine study is associated with Anesthesia. Her Anterior cingulate cortex study combines topics in areas such as Brain mapping and Thalamus.
Adrienne C. Lahti mostly deals with Schizophrenia, Neuroscience, Psychosis, Psychiatry and Antipsychotic. Her work carried out in the field of Schizophrenia brings together such families of science as Ketamine, Anterior cingulate cortex and Internal medicine, Hippocampus. Ketamine is the subject of her research, which falls under Anesthesia.
The study incorporates disciplines such as Glutamate receptor and NMDA receptor in addition to Neuroscience. Her Psychosis study combines topics from a wide range of disciplines, such as Audiology, Cognition, First episode, Pharmacology and Cerebral blood flow. Her study in Antipsychotic is interdisciplinary in nature, drawing from both Dopaminergic, Striatum and Treatment response.
Neuroscience, Schizophrenia, Psychosis, First episode psychosis and Antipsychotic are her primary areas of study. In Neuroscience, she works on issues like Glutamate receptor, which are connected to Pharmacology and Pathological. The Schizophrenia study combines topics in areas such as Anterior cingulate cortex, Cognition, Internal medicine and Glutamatergic.
Her Glutamatergic course of study focuses on Ketamine and Cerebral blood flow, Metabotropic glutamate receptor 2 and Brief Psychiatric Rating Scale. Psychosis is a subfield of Psychiatry that Adrienne C. Lahti studies. Her research investigates the connection between Antipsychotic and topics such as Metabolite that intersect with issues in Repeated measures design.
Her scientific interests lie mostly in Schizophrenia, Psychosis, Risperidone, Anterior cingulate cortex and Internal medicine. Her research integrates issues of Glutamate receptor, Glutamatergic and Cognition, Neuroscience in her study of Schizophrenia. Many of her studies involve connections with topics such as Modality and Neuroscience.
Her research investigates the connection with Psychosis and areas like Audiology which intersect with concerns in Putamen. The various areas that Adrienne C. Lahti examines in her Anterior cingulate cortex study include Antipsychotic and Stroop effect. Adrienne C. Lahti has researched Internal medicine in several fields, including White matter, Diffusion MRI, Fractional anisotropy, Endocrinology and Cardiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Subanesthetic doses of ketamine stimulate psychosis in schizophrenia
Adrienne C. Lahti;Bettylou Koffel;David LaPorte;David LaPorte;Carol A. Tamminga.
Effects of Ketamine in Normal and Schizophrenic Volunteers
Adrienne C Lahti;Martin A Weiler;B.A Tamara Michaelidis;Arti Parwani.
Decisional Capacity for Informed Consent in Schizophrenia Research
William T. Carpenter;James M. Gold;Adrienne C. Lahti;Caleb A. Queern.
Archives of General Psychiatry (2000)
Ketamine activates psychosis and alters limbic blood flow in schizophrenia.
Adrienne C. Lahti;Henry H. Holcomb;Deborah R. Medoff;Carol A. Tamminga.
Probing the human hippocampus using rCBF: contrasts in schizophrenia.
Deborah R. Medoff;Henry H. Holcomb;Adrienne C. Lahti;Carol A. Tamminga.
Gamma and Delta Neural Oscillations and Association with Clinical Symptoms under Subanesthetic Ketamine
L Elliot Hong;Ann Summerfelt;Robert W Buchanan;Patricio O'Donnell.
Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.
Nina Vanessa Kraguljac;Meredith Reid;David White;Rebecca Jones.
Psychiatry Research-neuroimaging (2012)
Increased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia
Nina V. Kraguljac;David M. White;Meredith A. Reid;Adrienne C. Lahti.
JAMA Psychiatry (2013)
SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma
Stephanie M. Robert;Susan C. Buckingham;Susan L. Campbell;Stefanie Robel.
Science Translational Medicine (2015)
Correlations Between rCBF and Symptoms in Two Independent Cohorts of Drug-Free Patients with Schizophrenia
Adrienne C Lahti;Martin A Weiler;Henry H Holcomb;Carol A Tamminga.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: